Veterinary Medicines Information website

GLUCADEX 2 MG/ML SOLUTION FOR INJECTION FOR HORSES, CATTLE, GOATS, PIGS, DOGS AND CATS

Authorised
  • Dexamethasone sodium phosphate
Download as PDF

Product identification

Medicine name:
GLUCADEX 2 MG/ML SOLUTION FOR INJECTION FOR HORSES, CATTLE, GOATS, PIGS, DOGS AND CATS
Active substance:
  • Dexamethasone sodium phosphate
Target species:
  • Cattle
  • Pig
  • Cat
  • Horse
  • Goat
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Periarticular use
  • Intravenous use
  • Intraarticular use

Product details

Active substance and strength:
  • Dexamethasone sodium phosphate
    2.63
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        2
        day
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        8
        day
      • Milk
        72
        hour
  • Periarticular use
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
  • Intravenous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Pig
      • Meat and offal
        6
        day
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
    • Goat
      • Meat and offal
        8
        day
      • Milk
        72
        hour
  • Intraarticular use
    • Horse
      • Meat and offal
        8
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Box with 1 bottle of 50 ml
  • Bow with 1 bottle of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kepro B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Kepro B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 124033
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0374/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Romania
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 14/03/2026
Download
Dutch (PDF)
Published on: 6/06/2024
Download

eu-puar-frv0374001-mr-rpe547-en.pdf

English (PDF)
Published on: 13/03/2026
Download